American Psychiatric Association, 168th Annual Meeting: Advisor's Introduction

Dear Colleagues,

We are delighted to share the peer-reviewed highlights of the 168th Annual Meeting of the American Psychiatric Association, held in Toronto, Canada, from May 16 to 20, 2015.

MD Conference Express® provides timely, peer-reviewed highlights of high-impact presentations from the live conference, long before they are published in the academic literature, and is a trusted education resource. The articles selected for this issue underwent a rigorous 5-step peer-review process to ensure their accuracy and provide a reliable interim information source prior to the research being vetted by the standard journal peer-review process.

The articles in this issue of MD Conference Express represent the most compelling topics of relevance to a broad array of practitioners and have the potential to influence clinical practice.

Among the clinical trial highlights presented are results showing improvements in patients with attention-deficit/hyperactivity disorder (ADHD). A randomized double-blind study showed that dasotraline was associated with meaningful improvements in measures of ADHD in adults, and the open-label CEES study found that controlled-release methylphenidate taken in the evening improved morning ADHD symptoms in children. In the setting of bipolar disorder, a pooled analysis showed that cariprazine provided meaningful improvement across a spectrum of symptoms.

The selected update articles include a review of a session that addressed the legal and medical issues related to medical and recreational marijuana and a session on strategies for managing treatment-resistant major depressive disorder. The feature article reviews the opening session conversation about opportunities for neuroscience in psychiatry, the role of advocacy, and challenges in addressing mental health.

We hope that you find the articles and practical perspectives that are contained in the pages of this issue of MD Conference Express helpful in integrating this new information into your clinical practice. For more information, please visit mdce.sagepub.com.

Patrick Ying, MD
Assistant Professor of Psychiatry
New York University Medical Center